MedscapeCME Cardiology Podcast show

MedscapeCME Cardiology Podcast

Summary: Medscape offers free CME activities for physicians and other health professionals. Medscape is organized by medical specialty, with each supported specialty having its own customized Web site. Specialty content is evaluated, created, and presented under the guidance of a Medscape program director and a medical professional advisory board.

Join Now to Subscribe to this Podcast

Podcasts:

 Cardiac Imaging to Predict Cardiac Events in Heart Failure Patients With and Without Preserved Ejection Fraction | File Type: 1 | Duration: $item.podcastDuration

Join Drs. Gersh and Udelson as they discuss the use of cardiac imaging in HF and SCA risk stratification strategies.

 Breaking Down Symptomatic DVT: Treatment Gaps in Recurrent Disease | File Type: 2 | Duration: $item.podcastDuration

Novel oral anticoagulants hold the promise of simplifying the treatment of acute and recurrent VTE; Drs Turpie, Agnelli, and Cohen discuss recent findings.

 New Stent Technologies: Clinical Applications of Evidence-Based Medicine | File Type: 2 | Duration: $item.podcastDuration

Drs. Meredith and Stone wrap up the hot topics in new developments in stent design from TCT 2011.

 Highlight on CETP: Role in Lipid Metabolism and Homeostasis | File Type: 2 | Duration: $item.podcastDuration

Join Dr. Rader as he discusses whether a change in HDL cholesterol level reflects proper HDL particle function or therapeutic success. And DISCUSS this topic with Dr. Rader.

 Advanced Prostanoid Therapy in PAH: The Time to Be Proactive Is Now! | File Type: 2 | Duration: $item.podcastDuration

Drs. Waxman, Frantz, and Chakinala discuss barriers to the use of prostanoid therapy in PAH management and when and how to use prostanoids.

 Addressing Residual Risk in the ACS Patient: Knowing the Numbers | File Type: 2 | Duration: $item.podcastDuration

Join Drs. Chapman, Gotto, and Kastelein as they discuss the results of AIM-HIGH and the latest CETP inhibitor clinical trials in HDL-targeted residual cardiovascular risk reduction.

 TAVI in the USA | File Type: 2 | Duration: $item.podcastDuration

After the PARTNER trial, the 2 PIs of the other US trial on transcatheter valves, Drs. Popma and Adams, give their take on stateside TAVI.

 Developments in the Treatment of Dyslipidemia: Are All Omega-3 Fatty Acids the Same? | File Type: 2 | Duration: $item.podcastDuration

Join our experts Drs. Miller, Schaefer, Jacobson, and Bays as they discuss current and future management of the patient with hyperlipidemia.

 HDL Quality: Is It a Better Target Than HDL-C? | File Type: 2 | Duration: $item.podcastDuration

Join Dr. Nicholls as he discusses the clinical significance of HDL-C for residual cardiovascular risk and whether HDL functionality would be a better predictor of therapeutic success. And DISCUSS this topic with Dr. Nicholls on Medscape Discuss.

 Innovations in Cardiac PET Imaging | File Type: 2 | Duration: $item.podcastDuration

Review recent advances in positron emission tomography and its impact on clinical practice.

 Mineral Homeostasis in CKD - Mineral and Bone Disorder: Evolving Concepts in Prevention and Treatment | File Type: 2 | Duration: $item.podcastDuration

Drs. Geoffrey Block, David Spiegel, Munro Peacock, and Kathleen Hill discuss calcium balance in CKD-MBD, including implications of new data.

 The Importance of Catheterization in the Assessment of Pulmonary Hypertension | File Type: 2 | Duration: $item.podcastDuration

Dr Krasuski highlights the pivotal role of RHC in the diagnosis and management of PAH.

 TCT 2011: Interventional Hot Topics | File Type: 2 | Duration: $item.podcastDuration

PARTNER, RIFLE, novel DES, and renal denervation – Drs. Worthley and Meredith give their take on the hot topics for the interventionalist.

 Prevention of Surgical Fires | File Type: 2 | Duration: $item.podcastDuration

Surgical fires can have a devastating impact on patients, but they may be preventable by understanding their causes and implementing risk-reduction strategies.

  Lipid Treatment Strategies in Patients With HIV: Statin Therapy Case Challenge | File Type: 2 | Duration: $item.podcastDuration

Join Drs. Underberg and Waters as they discuss dyslipidemia in patients with HIV, selection of statin therapy, and drug-drug interactions.

Comments

Login or signup comment.